Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2010

Nov 2, 2010

31802_dirs_2010-11-02_1cbe7b21-9346-4a94-ae39-e2c391a1b944.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2010-11-01

Reporting Person: Discovery Group I, LLC (10% Owner)
Reporting Person: Murphy Michael R (10% Owner)
Reporting Person: Donoghue Daniel J (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-01 Common Stock P 28847 $8.0979 Acquired 1347379 Indirect
2010-11-01 Common Stock P 4853 $8.0979 Acquired 230328 Indirect
2010-11-02 Common Stock P 31508 $8.0877 Acquired 230328 Indirect
2010-11-02 Common Stock P 5300 $8.0877 Acquired 235628 Indirect

Footnotes

F1: Discovery Group I, LLC is the General Partner of Discovery Equity Partners, L.P., which is a discretionary client of the reporting person, that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein

F2: Discovery Group I, LLC is an investment manager for Pleiades Investment Partners - D, L.P., which is a discretionary client of the reporting person, that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

F3: This transaction was executed in multiple trades at prices ranging from $8.00to $8.19. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."

F4: This transaction was executed in multiple trades at prices ranging from $7.90 to $8.15. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected